Predicting the Relative Efficacy of Shock Waveforms for Transthoracic Defibrillation in Dogs - 08/09/11
Abstract |
Study objective: Previous work has shown that a passive membrane model using a parallel resistor-capacitor circuit is capable of predicting optimal waveforms for transvenous defibrillation. This study tested the ability of that model to predict optimal waveforms for transthoracic defibrillation. Methods: This study was divided into 3 parts, each of which determined transthoracic defibrillation thresholds (DFTs) in 6 dogs for several different waveform shapes and durations. For each part, strength-duration relationships were determined from both experimental and model data and then compared with test model predictions. Part 1 DFTs were determined at various durations for 3 different monophasic waveforms—the ascending ramp, descending ramp, and square waveform. Part 2 DFTs were determined for 3 biphasic waveforms. Phase 1 was a 30-ms ascending ramp, and phase 2 was an ascending ramp, a descending ramp, or a square waveform. Part 3 DFTs were determined for 3 biphasic waveforms with very short second-phase durations. Phase 1 was a 30-ms ascending ramp, and phase 2 was a descending ramp. Results: For part 1, the model was able to predict the relative defibrillation efficacy of the 3 monophasic waveforms ( P <.05). For parts 2 and 3, the model was able to predict the biphasic waveforms with the lowest DFTs. These predictions were based on the criterion that the model response at the end of the second phase should return to or slightly pass the model response value at the beginning of the first phase. Conclusion: The resistor-capacitor model successfully predicted the relative defibrillation efficacy of several different waveforms delivered transthoracically. [White JB, Walcott GP, Wayland JL Jr, Smith WM, Ideker RE: Predicting the relative efficacy of shock waveforms for transthoracic defibrillation in dogs. Ann Emerg Med September 1999;34:309-320.]
Le texte complet de cet article est disponible en PDF.Plan
| From the Departments of Physiology and Biophysics, Biomedical Engineering, and Medicine, The University of Alabama at Birmingham, Birmingham, AL. |
|
| Supported by a National Institutes of Health research grant (No. HL-42760) and by a grant from Physio-Control Corporation, Redmond, WA. |
|
| Address for reprints: Raymond E Ideker, MD, PhD, 1670 University Boulevard, Room B140, Volker Hall, Birmingham, AL 35292-0019; 205-975-4710, fax 205-975-4720; E-mail rei@crml.uab.edu. |
|
| 0196-0644/99/$8.00 + 0 |
|
| ♢ | 47/1/100376 |
Vol 34 - N° 3
P. 309-320 - septembre 1999 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
